论文部分内容阅读
Aim: It was reported that phosphoprotein is involved in the regulation of ANP release.In this study, the effect of potassium bisperoxo(1,10-phenanthroline) oxovanadate [bpv(phen)], a protein tyrosine phosphatase inhibitor, in the regulation of atrial AN-P release was investigated.